Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Lower Bollinger Band Walk | Weakness | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Lower Bollinger Band Touch | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Bullish Engulfing | Bullish | 1.59% | |
Stochastic Buy Signal | Bullish | 1.59% | |
Doji - Bullish? | Reversal | 1.59% | |
Lower Bollinger Band Walk | Weakness | 1.59% | |
New 52 Week Low | Weakness | 1.59% | |
Outside Day | Range Expansion | 1.59% |
Alert | Time |
---|---|
Possible Inside Day | about 19 hours ago |
Up 3% | about 21 hours ago |
Up 2% | about 21 hours ago |
Up 1% | about 21 hours ago |
60 Minute Opening Range Breakout | about 21 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/07/2024
Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Tumor Pharmaceutical Products Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Tumor Pharmaceutical Products Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.56 |
52 Week Low | 0.54 |
Average Volume | 139,072 |
200-Day Moving Average | 0.86 |
50-Day Moving Average | 0.63 |
20-Day Moving Average | 0.63 |
10-Day Moving Average | 0.61 |
Average True Range | 0.04 |
RSI (14) | 33.77 |
ADX | 20.39 |
+DI | 9.59 |
-DI | 23.14 |
Chandelier Exit (Long, 3 ATRs) | 0.61 |
Chandelier Exit (Short, 3 ATRs) | 0.65 |
Upper Bollinger Bands | 0.71 |
Lower Bollinger Band | 0.56 |
Percent B (%b) | 0.09 |
BandWidth | 24.07 |
MACD Line | -0.02 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.0103 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.62 | ||||
Resistance 3 (R3) | 0.62 | 0.61 | 0.61 | ||
Resistance 2 (R2) | 0.61 | 0.59 | 0.61 | 0.61 | |
Resistance 1 (R1) | 0.59 | 0.58 | 0.60 | 0.59 | 0.61 |
Pivot Point | 0.57 | 0.57 | 0.58 | 0.57 | 0.57 |
Support 1 (S1) | 0.55 | 0.56 | 0.56 | 0.55 | 0.53 |
Support 2 (S2) | 0.54 | 0.55 | 0.54 | 0.53 | |
Support 3 (S3) | 0.52 | 0.54 | 0.53 | ||
Support 4 (S4) | 0.52 |